Quarterly report pursuant to Section 13 or 15(d)

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Detail)

v3.8.0.1
Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Detail) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Jan. 01, 2018
Schedule Of Equity Method Investments [Line Items]      
Impact of adoption of ASC Topic 606     $ 40,526
Receipt of common units due to annual common unit adjustment ("CUA") $ 5,012    
Equity in earnings 8,636 $ 10,060  
NCM      
Schedule Of Equity Method Investments [Line Items]      
Beginning Balance 200,550    
Beginning Balance (351,706)    
Equity in earnings 4,015 $ 3,241  
Ending Balance 202,455    
Ending Balance (299,222)    
Investment In NCM      
Schedule Of Equity Method Investments [Line Items]      
Beginning Balance 200,550    
Receipt of common units due to annual common unit adjustment ("CUA") 5,012    
Receipt of excess cash distributions (7,122)    
Equity in earnings 4,015    
Ending Balance 202,455    
Deferred Revenue      
Schedule Of Equity Method Investments [Line Items]      
Beginning Balance (351,706)    
Impact of adoption of ASC Topic 606 [1]     $ 53,605
Receipt of common units due to annual common unit adjustment ("CUA") (5,012)    
Ending Balance (299,222)    
Deferred Revenue | NCM      
Schedule Of Equity Method Investments [Line Items]      
Receipt of common units due to annual common unit adjustment ("CUA") 5,012    
Amortization of deferred revenue 3,891    
Distributions from NCM      
Schedule Of Equity Method Investments [Line Items]      
Receipt of excess cash distributions (6,358)    
Ending Balance (6,358)    
Equity in Earnings      
Schedule Of Equity Method Investments [Line Items]      
Ending Balance (4,015)    
Equity in Earnings | NCM      
Schedule Of Equity Method Investments [Line Items]      
Equity in earnings (4,015)    
Other Revenue      
Schedule Of Equity Method Investments [Line Items]      
Revenues earned under ESA [2],[3] (7,967)    
Ending Balance (11,858)    
Other Revenue | NCM      
Schedule Of Equity Method Investments [Line Items]      
Amortization of deferred revenue (3,891)    
Interest Expense - NCM      
Schedule Of Equity Method Investments [Line Items]      
Revenues earned under ESA [2],[3] 4,979    
Ending Balance [3] 4,979    
Cash Received      
Schedule Of Equity Method Investments [Line Items]      
Revenues earned under ESA [2],[3] 2,988    
Receipt of excess cash distributions 13,480    
Ending Balance $ 16,468    
[1] As a result of adoption of ASC Topic 606, the Company determined that the deferred revenue associated with the ESA and Common Unit Adjustment agreement should be amortized on a straight-line basis versus the units of revenue method followed prior to adoption. The Company recorded a reduction in the deferred revenue balance and a cumulative effect of a change in accounting principle in retained earnings (see also Note 6). See Note 3 for further discussion of the impact of the adoption of ASC Topic 606.
[2] Amount includes the per patron and per digital screen theatre access fees due to the Company, net of amounts paid to NCM for on-screen advertising time provided to the Company’s beverage concessionaire of approximately $2,961.
[3] Reflects impact of significant financing component related to amounts received in advance under the ESA and CUA agreements. See Note 3.